Zeev's Turnips Patch-No Politics (ZEEV)

[findit]

Osur fundaments are not good. They do not make a profit, but they sure to have the inside track on getting the HIV test business in Africa as the administration pushes its AIDS program over the next few years. OSUR shareholders might want to look at TRIB too and play both. TRIB has a HIV test that is marketed in Africa now and it produces faster test results than OSUR. It has been held down due to not 'working' the FDA professionally over the years. This has delayed their HIV test approval here. But they are selling it worldwide and unlike OSUR they are profitable. It has moved up some to the 1.50 area lately, but is still way undervalued. They think they will get HIV test approval here by summer. Since the Africa aid push is to begin in 2004, they should have FDA approval in hand and be quite competitive with OSUR here and in Africa by then. In the long run, price appreciation for TRIB may be greater than OSUR. What do you OSUR holder's think?